SCI Abstract

search
+
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation
Objective: The aim of this study was to estimate the recurrence risk based on the number of progn
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer
Objective: We represent Sprouty 2 (Spry2) expression analysis and its association with key driver
MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors
MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors
Background: Liver tumors are commonly encountered in oncology. The study aimed to assess the impa
Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database
Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database
Objectives: Metaplastic breast carcinoma (MBC) is a rare, aggressive form of cancer comprising ep
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
Objectives: Angiosarcoma is a rare complication of breast-conserving therapy. This study evaluate
A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
Background: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors are standard thera
Genomic and Molecular Characteristics of Ovarian Carcinosarcoma
Genomic and Molecular Characteristics of Ovarian Carcinosarcoma
Ovarian carcinosarcoma (OCS) is a rare malignancy with a poor prognosis. It is a biphasic tumor with
Does the Shift Away From Frame-based Stereotactic Radiosurgery Endanger Radiation Oncology’s Seat at the Table in Treating Functional Disorders?
Does the Shift Away From Frame-based Stereotactic Radiosurgery Endanger Radiation Oncology’s Seat at the Table in Treating Functional Disorders?
Departments of Radiation Oncology and Neurological Surgery, University Hospitals Seidman Cancer Center Case Western...
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases: An NCDB Time-to-event Cohort
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases: An NCDB Time-to-event Cohort
Background: The primary site and histology of systemic malignancy are known predictors of progres
Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning
Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning
Objectives: Distinguishing between radiation necrosis (RN) and metastatic progression is extremel
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer
Objective: Non–small cell lung cancer (NSCLC) is a devastating but universal class of lung carcin
Geographic Disparities in Access to Cancer Clinical Trials in Canada
Geographic Disparities in Access to Cancer Clinical Trials in Canada
Objective: This study aims to evaluate geographic disparities in access to cancer clinical trials
Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score–matched NCDB Analysis
Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score–matched NCDB Analysis
Objective: Stereotactic body radiation therapy (SBRT) for early-stage non–small cell carcinoma of
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Objectives: To systematically evaluate the effectiveness and safety of neoadjuvant immunotherapy
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy
Background: Accuracy of tumor bed (TB) delineation is essential for targeting boost doses or part
Treatment of Cancer Pain: A Systematic Review
Treatment of Cancer Pain: A Systematic Review
Contextualization: One of the biggest problems regarding the treatment of cancer patients is pain
Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020
Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020
Objectives: To analyze the evolution of clinical outcomes derived from clinical trials on first-l
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma
Objective: The objective of this study was to investigate the prognostic significance of the dept
The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy
The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy
Currently, multidrug combinations are often used clinically to improve the efficacy of oncology chem
Management Strategies and Outcomes in Primary Liver Angiosarcoma
Management Strategies and Outcomes in Primary Liver Angiosarcoma
Objectives: Primary hepatic angiosarcoma is a rare tumor of the liver that originates from endoth
Effect of Frailty on Hospital Outcomes Among Pediatric Cancer Patients in the United States: Results From the National Inpatient Sample
Effect of Frailty on Hospital Outcomes Among Pediatric Cancer Patients in the United States: Results From the National Inpatient Sample
Background: Studies on frailty among pediatric patients with cancer are scarce. In this study, we
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval
Objective: The aim of this study was to evaluate the progression-free survival (PFS) and overall
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy, characterized by a high death-to-incidence
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma: A Systematic Review
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma: A Systematic Review
Low-grade myofibroblastic sarcoma (LGMS) is a rare malignancy that commonly occurs in the head and n
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer: A Propensity Score Matching Cohort Study and Cumulative Meta-analysis
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer: A Propensity Score Matching Cohort Study and Cumulative Meta-analysis
Objectives: Carcinoembryonic antigen (CEA) is the most frequently used tumor marker for non-small
Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor
Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor
Objectives: Clinicopathologic features and recurrence rates of inverted noninvasive urothelial pa
Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees
Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees
Objective: The objective of this study was to evaluate trends in prevalence of cervical cancer (C
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model
Objectives: Competing risk models were used in this study. The purpose of this study was to asses
Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment
Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment
Objectives: Immune checkpoint inhibitors (ICI) can cause immune-related adverse events (irAEs) su
Prognostic Analysis of Lymphovascular Invasion in Stages I–III Colorectal Cancer: A Retrospective Study Based on Propensity Score Match
Prognostic Analysis of Lymphovascular Invasion in Stages I–III Colorectal Cancer: A Retrospective Study Based on Propensity Score Match
Introduction: Lymphovascular invasion (LVI) is a micropathological tumor factor believed to incre
Load More
format_indent_increase